Cyclosporin and discoid lupus erythematosus

British Journal of Dermatology

Volumn 131, Issue 1, 1994, Pages 132-133

  Yell, J A ^a   Burge, S M ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; GOLD; POTASSIUM; URIC ACID;

ADULT; BIOPSY; CASE REPORT; CREATININE BLOOD LEVEL; DEPRESSION; DISCOID LUPUS ERYTHEMATOSUS; DOSE RESPONSE; FEMALE; HUMAN; LETTER; LIVER FUNCTION; MALE; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADULT; CASE REPORT; CYCLOSPORINE; HUMAN; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0028030385     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1994.tb08471.x     Document Type: Letter

References (12)

1. Contingent genetic regulatory events in T lymphocyte activation
2. Signal transmission pathways and lymphocyte function
3. Cyclosporine in nonpsoriatic dermatoses
4. Cyclosporin: use outside transplantation. Promising, but long term follow up is essential
5. Spontaneous murine lupus‐like syndromes: clinical and immunopathological manifestation in several strains
6. 2)‐cyclosporin: I. Reduction of autoantibodies
7. Cyclosporine in the treatment of lupus erythematosus
8. The effects of cyclosporine in patients with systemic lupus
9. Effects of cyclosporine in severe systemic lupus erythematosus
10. Can cyclosporin A be used without steroids in systemic lupus erythematosus
11. Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A
12. The ‘connective tissue diseases